237
Participants
Start Date
July 31, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Secukinmab
Secukinumab was supplied as a 150mg lyophiized cake in individual glass vials each. The study drug dose levels were 25mg, 75mg, 150mg and 300mg and was administered subcutaneously.
Placebo
Secukinumab placebo was supplied as a 150mg lyophiized cake in individual glass vials each. The placebo dose levels were 25mg, 75mg, 150mg and 300mg and was administered subcutaneously.
Novartis Investigative Site, Changhua
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Gyula
Novartis Investigative Site, Berlin
Novartis Investigative Site, Rochester
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Greenville
Novartis Investigative Site, Hildesheim
Novartis Investigative Site, Jackson
Novartis Investigative Site, Taichung
Novartis Investigative Site, Taichung
Novartis Investigative Site, Taichung
Novartis Investigative Site, Kalamazoo
Novartis Investigative Site, Pardubice
Novartis Investigative Site, Springfield
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Ostrava
Novartis Investigative Site, Little Rock
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, München
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Coeur d'Alene
Novartis Investigative Site, Mesa
Novartis Investigative Site, Peoria
Novartis Investigative Site, Santa Monica
Novartis Investigative Site, Bayreuth
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Tver'
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Tula
Novartis Investigative Site, Tulsa
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Prague
Novartis Investigative Site, Iizuka
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Sagamihara
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Kawagoe
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lublin
Novartis Investigative Site, Košice
Novartis Investigative Site, Piešťany
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Busan
Novartis Investigative Site, Anyang-si
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY